22+ hour, 10+ min ago   (197+ words) / Alessia Baccarini, Alexander Tepper, Bhavya Singh, Brian D. Brownsvg, cancer,, Alessia Baccarini, Alexander Tepper, Bhavya Singh, Brian D. Brownsvg, cancer, Chiara Falcomatà, Cosimo Commisso, Divya Chhamalwan, Gurkan Mollaoglu, Hunter T. Potak, Icahn School of Medicine at Mount Sinai, Matthew D. Park, Maxime…...

1+ day, 4+ hour ago   (149+ words) Gilead Research Scholars Program in Solid Tumors 2026 Oncodaily Gilead Research Scholars Program in Solid Tumors 2026 The Gilead Research Scholars Program in Solid Tumors 2026 supports early-career investigators conducting independent basic or clinical research addressing unmet needs in breast, endometrial, ovarian, or…...

1+ day, 1+ hour ago   (253+ words) Myeloma Paper of the Day, September 13th, Suggested by Robert Orlowski / Anastasia Zekeridou, Andre de Menezes Silva Corraes, Blood Cancer Journal, cancer,, Anastasia Zekeridou, Andre de Menezes Silva Corraes, Blood Cancer Journal, cancer, Christoph Schaefers, Darin Carabenciov, Erin Wiedmeier-Nutor, Joselle Cook,…...

1+ day, 53+ min ago   (100+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

1+ day, 17+ hour ago   (194+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

4+ day, 5+ hour ago   (208+ words) Liang Cheng, Director of Anatomic and Molecular Pathology at Brown Pathology and Laboratory Medicine, shared on LinkedIn: “In case you missed my earlier post, here’s the companion (twin!) comprehensive review on prostatic neuroendocrine tumors, published in Endocrine Pathology, written by…...

5+ day, 20+ hour ago   (50+ words) Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared on X: “Spot on talk by Xue-Yan Jiang immunotherapy as a double-edged sword. While IO revolutionises cancer care, managing irAEs remains key. We needed predictors, early clinical markers and…...

6+ day, 1+ hour ago   (88+ words) The Babak Lab shared on LinkedIn: “Merck and Moderna have announced positive top-line results from the Phase 3 INTerpath-001 trial of intismeran autogene (V940) + pembrolizumab in patients with resected high-risk melanoma. INTerpath-001 is the first positive Phase 3 trial of an individualized neoantigen…...

6+ day, 21+ hour ago   (126+ words) Lung Cancer Europe shared on LinkedIn: “Changes after immunotherapy starts may be more informative than a sample taken before treatment begins. New research published in Cancer Cell looked at how the tumour immune environment changes during checkpoint inhibitor treatment. The…...

1+ week, 1+ hour ago   (156+ words) Eleonora Dondossola, Assistant Professor in the Department of Genitourinary Medical Oncology – Research, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, shared on LinkedIn: “Big celebrations for my first R01! This funding will allow us to investigate…...